Back to all news
AI Model Predicts Colorectal Cancer Survival by Integrating Clinical and Molecular Data
A research team developed a machine learning model that predicts colorectal cancer survival using combined clinical and molecular features, achieving high accuracy.
Key Details
- 1Study analyzed data from over 500 colorectal cancer patients using clinical (age, stage, chemotherapy) and molecular (gene/microRNA) features.
- 2Adaptive boosting ML model achieved 89.58% accuracy for survival prediction.
- 3Key predictive features included pathological stage, E2F8 gene expression, WDR77, and hsa-miR-495-3p microRNA.
- 4Combining clinical and biological data outperformed models using either data type alone.
- 5Study used publicly available data from the TCGA database; patient lifestyle factors were not included but seen as important for future work.
Why It Matters
The integration of clinical and molecular data using machine learning could enhance personalized risk stratification and treatment planning in colorectal cancer, an area of substantial clinical need. Such research advances the potential for AI-driven precision medicine in oncology and radiology.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
AI-Driven Handheld Endomicroscope Enhances Early Cancer Detection
Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.
•EurekAlert
AI Model Uses EKG and EHR Data to Predict Sudden Cardiac Arrest
Researchers have developed AI models that analyze EKG and EHR data to predict risk of sudden cardiac arrest in the general population.